semaglutide & tirzepatide weight loss vs Tirzepatide: Which Is Better for Loss? Semaglutide vs Tirzepatide for Weight

Frontiers In Endocrinology

Ozempic (Semaglutide for Diabetes) Available in South Africa since 2019 Approved use: Type 2 diabetes management Dosage: Lower doses (up to 1 mg once weekly in SA, higher doses like 2 mg in some markets) Average weight loss: 10-20% of body weight in clinical trials Other benefits: Improves blood sugar control, lowers HbA1c, reduces cardiovascular risks in diabetics In South Africa, Ozempic is not officially approved for weight loss , though some doctors prescribe it off-label to help with obesity

doi: 10.1016/j.celrep.2019.03.024

The author is not a licensed financial advisor, broker-dealer, or tax professional

Pubmed Data : Case Rep Rheumatol

Although Ozempic and Wegovy both contain Semaglutide, they are licensed for different things and one should not be used for the other